Valeant-Enron like...

Reitz has filed papers in two Los Angeles courthouses laying out details of what he and his lawyer call "a massive fraud."

Valeant became one of the hottest healthcare stocks in recent years by buying other firms' medicines and then swiftly hiking their prices by as much as 500%.

Specialty pharmacies such as Philidor are part of a little-known strategy by Valeant and other pharmaceutical companies to sell high-priced drugs that insurers otherwise wouldn't pay for.

Many of Valeant's expensive brand-name medicines including Jublia for toenail fungus and Solodyn for acne are similar to generic medicines available for far less. When patients fill those prescriptions at the pharmacy, insurers often require the druggist to switch to the generic causing Valeant to lose the sale.

To get around that blockade, Valeant has been distributing coupons on the Internet and to doctor's offices that allow patients to lower or even avoid a co-pay if they ordered the drugs through Philidor. 

A federal securities fraud class action is brought on behalf of  all persons and entities who purchased or otherwise acquired the securities of Valeant between February 23, 2015 and October 20, 2015, inclusive, seeking to pursue remedies under the Securities Exchange Act of 1934.

How can Seniors afford the medicine?   Just a Nightmare thought.